Viewing StudyNCT03965858



Ignite Creation Date: 2024-05-06 @ 1:13 PM
Last Modification Date: 2024-10-26 @ 1:10 PM
Study NCT ID: NCT03965858
Status: COMPLETED
Last Update Posted: 2020-04-28
First Post: 2019-05-21

Brief Title: Efficacy Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression
Sponsor: Celon Pharma SA
Organization: Celon Pharma SA

Conditions & Keywords Data

Conditions:
Name
Major Depressive Disorder
Keywords: